PHARMACEUTICALLY ACCEPTABLE SALT AS RENAL OUTER MEDULLARY POTASSIUM CHANNEL INHIBITOR

• 收藏
• 分享

专利权人:

Jiangsu Hengrui Medicine Co.; Ltd.

发明人:

Yun LU,Qiyun SHAO,Guaili WU,Jun FENG

申请号：

US16305644

公开号：

US20200123135A1

申请日:

2017.06.06

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A pharmaceutically acceptable salt as a renal outer medullary potassium channel (ROMK) inhibitor, specifically an L-tartrate and a crystal form I and crystal form II thereof, is described. The pharmaceutically acceptable salt of the ROMK inhibitor, specifically the L-tartrate, has improved bioavailability and stability.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/